Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report

Table 1 MRI characteristics over 12 weeks of treatment

	Baseline	6 weeks	12 weeks
STIR hyperintensity/muscle + STIR positivity	0.02	0.03	0.03
Fat fraction	0.27	0.28	0.27

ISSN: 1471-2474